AGE, GENDER, AND NONMODULATION - A SEXUAL DIMORPHISM IN ESSENTIAL-HYPERTENSION

Citation
Ndl. Fisher et al., AGE, GENDER, AND NONMODULATION - A SEXUAL DIMORPHISM IN ESSENTIAL-HYPERTENSION, Hypertension, 29(4), 1997, pp. 980-985
Citations number
38
Categorie Soggetti
Peripheal Vascular Diseas
Journal title
ISSN journal
0194911X
Volume
29
Issue
4
Year of publication
1997
Pages
980 - 985
Database
ISI
SICI code
0194-911X(1997)29:4<980:AGAN-A>2.0.ZU;2-Y
Abstract
The angiotensinogen gene is one of the very few related by linkage ana lysis to human hypertension, but the linkage has been consistently sho wn only among males. Moreover, polymorphisms in this gene predict an a bnormal renal responsiveness to angiotensin II, a feature of non-modul ation, but again, only among males. To pursue these related bridges be tween genetics and physiology, we evaluated the effects of sex on a se cond feature of non-modulation, the aldosterone response to infused an giotensin II during low sodium balance. We tested the resultant hypoth esis-that non-modulation would be less frequent in women-by conducting identical protocols on 225 hypertensive inpatients (70 women, 155 men ). Non-modulation was strikingly less frequent among women (26%; 95% c onfidence interval, 16% to 37%) than men (49%; 95% confidence interval , 40% to 57%) (P=.001). We tested the hypothesis that sex steroids pla y a role by comparing young, premenopausal women (<35 years) with wome n who were perimenopausal (45 to 55 years) and postmenopausal (>55 yea rs). Among the youngest women, the frequency of nonmodulation was only 7%, significantly less than in young men (41%, P=.02). A steady incre ase in non-modulation frequency accompanied advancing age in women, re aching 47% in those older than 55 years, equal to the fraction of men affected. Age influenced non-modulation frequency in men far less. We conclude that a striking sex difference underlies the nonmodulation ph enotype and that female sex hormones may confer protection against a g enotypic predisposition in women. This ''override'' of genotype, manif est by a very low frequency of non-modulation in young women, may part icipate in their known protection against cardiovascular disease.